Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.

Griggs RC, Miller JP, Greenberg CR, Fehlings DL, Pestronk A, Mendell JR, Moxley RT 3rd, King W, Kissel JT, Cwik V, Vanasse M, Florence JM, Pandya S, Dubow JS, Meyer JM

Open source

DOI
10.1212/wnl.0000000000003217
Published
2016 Nov 15
Container
Neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1212/wnl.0000000000003217,
  title = {Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.},
  author = {Griggs RC and Miller JP and Greenberg CR and Fehlings DL and Pestronk A and Mendell JR and Moxley RT 3rd and King W and Kissel JT and Cwik V and Vanasse M and Florence JM and Pandya S and Dubow JS and Meyer JM},
  year = {2016},
  journal = {Neurology},
  doi = {10.1212/wnl.0000000000003217},
  url = {https://doi.org/10.1212/wnl.0000000000003217}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
AU  - Griggs RC
AU  - Miller JP
AU  - Greenberg CR
AU  - Fehlings DL
AU  - Pestronk A
AU  - Mendell JR
AU  - Moxley RT 3rd
AU  - King W
AU  - Kissel JT
AU  - Cwik V
AU  - Vanasse M
AU  - Florence JM
AU  - Pandya S
AU  - Dubow JS
AU  - Meyer JM
PY  - 2016
JO  - Neurology
DO  - 10.1212/wnl.0000000000003217
UR  - https://doi.org/10.1212/wnl.0000000000003217
ER  - 

APA

RC, G., JP, M., CR, G., DL, F., A, P., JR, M., 3rd, M. R., W, K., JT, K., V, C., M, V., JM, F., S, P., JS, D., & JM, M. (2016). Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.. Neurology. https://doi.org/10.1212/wnl.0000000000003217

Source records